Last reviewed · How we verify

Nicotine replacement therapy sampling

The University of Hong Kong · FDA-approved active Small molecule

Nicotine replacement therapy delivers nicotine through non-combustible routes to satisfy nicotine dependence and reduce withdrawal symptoms during smoking cessation.

Nicotine replacement therapy delivers nicotine through non-combustible routes to satisfy nicotine dependence and reduce withdrawal symptoms during smoking cessation. Used for Smoking cessation aid, Reduction of nicotine withdrawal symptoms.

At a glance

Generic nameNicotine replacement therapy sampling
Also known asNRT sample, Nicoderm, Nicorette, Nicotine Replacement Therapy
SponsorThe University of Hong Kong
Drug classNicotinic receptor agonist
TargetNicotinic acetylcholine receptors
ModalitySmall molecule
Therapeutic areaAddiction Medicine / Smoking Cessation
PhaseFDA-approved

Mechanism of action

Nicotine binds to nicotinic acetylcholine receptors in the central and peripheral nervous system, mimicking the effects of inhaled nicotine from cigarettes. By providing controlled nicotine doses without the harmful combustion byproducts of tobacco smoke, NRT reduces cravings and withdrawal symptoms, facilitating smoking cessation. The therapy is typically used as part of a comprehensive smoking cessation program that may include behavioral support.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: